Dr1 - OmicsDI

Show results for

Unknown (191)
Transcriptomics (49)
Genomics (36)
Proteomics (7)
Genomic (1)
Metabolomics (1)

Organisms

Homo sapiens (20)
Acinetobacter oleivorans DR1 (13)
Mus musculus (8)
Saccharomyces cerevisiae (6)
Alphavirus (5)
Anemia (5)
Archaea (5)
Bacteria (5)
Betaherpesvirinae (5)
Borrelia (5)
Clostridium perfringens (5)
Cytomegalovirus (5)
Dengue virus (5)
Eukaryota (5)
Hepatitis B virus (5)
Human alphaherpesvirus 1 (5)
Human betaherpesvirus 5 (5)
Human immunodeficiency virus (5)
Influenza A virus (5)
Influenza C virus (5)
Japanese encephalitis virus group (5)
Kamptonema sp. (5)
Listeria monocytogenes (5)
Bos indicus (3)
Acinetobacter oleivorans (3)
Mus spretus (1)
Bos taurus (1)
Candida albicans (1)
Rattus norvegicus (1)
Sorghum bicolor (1)

Organisms

Acinetobacter oleivorans DR1 (11)
Homo sapiens (5)
Acinetobacter oleivorans (3)
Sorghum bicolor (2)
Mus musculus (2)
Deinococcus indicus (1)
Hepadnaviridae (1)
Glycine max (1)
Pseudomonas aeruginosa (1)

Repository

biostudies-arrayexpress (40)
ENA (28)
geo (15)
pride (5)
EGA (2)
dbGaP (1)
jPOST (1)
MassIVE (1)
MetaboLights (1)

Tissue

Cell suspension culture (2)
Brain (1)
Lymph node (1)
Spleen (1)
Tissue (1)

Disease

Atypical teratoid rhabdoid tumor (1)

Technology Type

Mass Spectrometry (5)
Affinity purification coupled with mass spectrometry proteomics (2)
Shotgun proteomics (2)
Mass spectrometry assay (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)

Instrument Platform

NEXTflex Small-RNA Seq kit v3 (Perkin Elmer) & NEXTflex Rapid XP DNA-seq kit v2 (Perkin Elmer) (1)
Direct-zol RNA microprep kit (Zymo Research), LabChip RNA pico sensitivity assay, Perkin Elmer & Nucleospin RNA kit (Macherey Nagel) (1)
PALM type 4 microscope (Zeiss) (1)
G2505A DNA microarray scanner [Agilent] (1)
G2565BA DNA microarray scanner [Agilent] (1)
NextSeq 2000 (1)
Q Exactive (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2013 (10)
2010 (10)
2014 (8)
2012 (6)
2015 (4)
2025 (3)
2016 (3)
2008 (3)
2007 (3)
2022 (3)
2011 (2)
2018 (2)
2009 (1)
2023 (1)
2019 (1)
2024 (1)
2026 (1)
2017 (1)

First Public Date

2013 (7)
2014 (6)
2023 (3)
2026 (2)
2021 (2)
2016 (2)
2015 (2)
2025 (1)
2019 (1)
2018 (1)
2017 (1)

Classification

viruses (1)
bacteria (1)

Study type

Transcription profiling by array (18)
RNA-seq of coding RNA (12)
Unknown experiment type (2)
Comparative genomic hybridization by array (2)
ChIP-seq (2)
ChIP-chip by tiling array (1)
ChIP-chip by array (1)
Methylation profiling by array (1)
RNA-seq of total RNA (1)

Release Date

2010 (16)
2014 (15)
2022 (15)
2013 (14)
2012 (14)
2023 (14)
2025 (13)
2021 (11)
2019 (11)
2018 (11)
2007 (10)
2015 (9)
2011 (9)
2024 (9)
2020 (9)
2017 (9)
2016 (8)
2009 (7)
2008 (6)
2006 (4)
2002 (4)
2004 (3)
1999 (3)
2026 (2)
2005 (2)
2001 (1)
2000 (1)
1997 (1)

Lab affiliation

Children’s Hospital, University Medical Center Würzburg, Germany (1)
Institute of Microbiology of the CAS (1)
Jean-Michel CAMADRO, PhD DR1 CNRS "Mitochondria, Metals and Oxidative Stress" group leader Head "Mass Spectrometry Lab and Proteomics core Facility" Jacques Monod Institute UMR7592 CNRS - Paris University 15 rue Hélène Brion 75205 Paris Cedex 13, FRANCE (1)
Jean-Michel CAMADRO, PhD DR1 CNRS "Mitochondria, Metals and Oxidative Stress" group leader Head "Mass Spectrometry Lab and Proteomics core Facility" Jacques Monod Institute UMR7592 CNRS - Paris University 15 rue Hélène Brion 75205 Paris Cedex 13, FRANCE tel : 33(1)57278029 (1)
Professor Anthony W Purcell Deputy Head (Research), Department of Biochemistry and Molecular Biology Head Immunoproteomics Laboratory Monash University, Clayton Campus Clayton 3800 Victoria Australia (1)

Previous page
1 / 29
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 29
Next page

Sort by:

Relevance

Page size

Multi-omics reveals the DR5-FXR-CHPT1 axis governs hepatocyte pyroptosis via glycerophospholipid remodeling after major partial hepatectomy

Acute liver injury following major partial hepatectomy (PHx), manifesting as small-for-size syndrome (SFSS) and post-hepatectomy liver failure (PHLF), carries high mortality. However, the key mechanisms underlying irreversible remnant liver injury and cell death remain poorly understood, particularl...

2026-08-16 | MTBLS14980 | MetaboLights

Acinetobacter oleivorans DR1 : Wild-type cell harboring plasmid (pAST2) in nutrient media

Transcriptional profiling of A. oleivorans DR1 cells harboring pAST2. Plasmid pAST2 is a tetracycline-resistance plasmid which was isolated from activated sludge (Hong et al., 2014). The complete plasmid sequence was deposited in the National Center for Biotechnology Information (NCBI) GenBank under...

ORGANISM(S): Acinetobacter oleivorans DR1

2014-02-22 | E-GEOD-55239 | biostudies-arrayexpress

Acinetobacter oleivorans DR1

Transcriptome of Acinetobacter oleivorans DR1

PRJNA271200 | ENA

Acinetobacter oleivorans DR1

Acinetobacter sp. DR1 Genome sequencing

PRJNA46105 | ENA

Acinetobacter oleivorans DR1

Acinetobacter oleivorans DR1 Transcriptome or Gene expression

PRJNA312045 | ENA

Acinetobacter oleivorans DR1 : Cell treated Ampicillin 100 M-BM-5g/ml in nutrient media

Transcriptional profiling of A. oleivorans DR1 treated Ampicillin 100 M-BM-5g/ml for 15min . To identify effect of ampicillin in A. oleivornas DR1, the cells were grown to exponential phase (OD600 ~0.4) and treated ampicillin 100 M-BM-5g/ml for 15 min.

ORGANISM(S): Acinetobacter oleivorans DR1

2014-06-03 | E-GEOD-58166 | biostudies-arrayexpress

Acinetobacter oleivorans DR1 : Cell treated Kanamycin 4 M-BM-5g/ml in nutrient media

Transcriptional profiling of A. oleivorans DR1 treated Kanamycin 4M-BM-5g/ml for 15min . To identify effect of kanamycin in A. oleivornas DR1, the cells were grown to exponential phase (OD600 ~0.4) and treated kanamycin 4M-BM-5g/ml for 15 min.

ORGANISM(S): Acinetobacter oleivorans DR1

2014-06-03 | E-GEOD-58167 | biostudies-arrayexpress

Acinetobacter oleivorans DR1

Acinetobacter oleivorans DR1 : WT stationary phase vs. aqsR mutant stationary phase

PRJNA189511 | ENA

Acinetobacter oleivorans DR1

Acinetobacter oleivorans DR1 : Wild type treated with tetracycline vs. harboring plasmid (pAST2) treated with tetracycline

PRJNA189955 | ENA

Acinetobacter oleivorans DR1

Acinetobacter oleivorans DR1: paraquat-treated and phenazine methosulfate-treated

PRJNA288423 | ENA